Hypoxia-Induced Gene Expression in Chemoradioresistant Cervical Cancer Revealed by Dynamic Contrast-Enhanced MRI

Cathinka Halle, Erlend Andersen, Malin Lando, +9

Cancer Research

Oncologic ImagingFunctional Magnetic ResonanceIncreased HypoxiaCancer BiologyTumor Biology +16

The protein phosphatase 1 regulator PNUTS is a new component of the DNA damage response

Helga B. Landsverk, Felipe Mora‐Bermúdez, Ole J.B. Landsverk, +7

EMBO Reports

Reductive StressGenome InstabilityProtein FunctionDna DamageBiochemistry +9

Combined inhibition of Wee1 and Chk1 gives synergistic DNA damage in S-phase due to distinct regulation of CDK activity and CDC45 loading

Sissel Hauge, Christian Naucke, Grete Hasvold, +5

Oncotarget

Molecular RegulationApoptosisGenomic MechanismMolecular BiologyCell Death +14

Human Adipose-Derived Mesenchymal Stem Cells Respond to Short-Term Hypoxia by Secreting Factors Beneficial for Human Islets in Vitro and Potentiate Antidiabetic Effect in Vivo

Simen W. Schive, Mohammad Reza Mirlashari, Grete Hasvold, +7

Cell Medicine

Targeting lung cancer through inhibition of checkpoint kinases

Randi G. Syljuåsen, Grete Hasvold, Sissel Hauge, +1

Frontiers in Genetics

Checkpoint KinasesMedicinePathologyBronchial NeoplasmImmune Checkpoint Inhibitor +8

p53‐dependent G₁ arrest in 1st or 2nd cell cycle may protect human cancer cells from cell death after treatment with ionizing radiation and Chk1 inhibitors

L. Petersen, Grete Hasvold, Jiří Lukáš, +2

Cell Proliferation

Hypoxia‐induced alterations of G2 checkpoint regulators

Grete Hasvold, Christin Lund‐Andersen, Malin Lando, +5

Molecular Oncology

Differential Effects of Combined ATR/WEE1 Inhibition in Cancer Cells

Gro Elise Rødland, Sissel Hauge, Grete Hasvold, +4

Cancers

U2os Osteosarcoma CellsTumor BiologyOncologyWee1 InhibitionMedicine +12

Determination of Tacrolimus Concentration and Protein Expression of P-Glycoprotein in Single Human Renal Core Biopsies

Veronica Krogstad, Nils Tore Vethe, Ida Robertsen, +9

Therapeutic Drug Monitoring

The Efficacy of CHK1 Inhibitors Is Not Altered by Hypoxia, but Is Enhanced after Reoxygenation

Grete Hasvold, Viola Nähse, Kinga Tkacz-Stachowska, +2

Molecular Cancer Therapeutics